Aptomed Medicines India Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 30-12-2024
- Paid Up Capital ₹ 2.40 M
as on 30-12-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.80 M
as on 30-12-2024
- Revenue %
(FY 2020)
- Profit 16.95%
(FY 2020)
- Ebitda 43.25%
(FY 2020)
- Net Worth -30.55%
(FY 2020)
- Total Assets -4.66%
(FY 2020)
About Aptomed Medicines India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.40 M.
The company currently has active open charges totaling ₹4.80 M.
Deepak Chaturvedi, Samirkumar Shah, and Vrushali Khan serve as directors at the Company.
- CIN/LLPIN
U33111UP2008PTC034675
- Company No.
034675
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2008
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Hathras, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aptomed Medicines India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vrushali Khan  | Director | 29-Jun-2013 | Current |
| Deepak Chaturvedi | Director | 19-Feb-2008 | Current |
| Samirkumar Shah | Director | 01-Sep-2016 | Current |
Financial Performance of Aptomed Medicines India.
Aptomed Medicines India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 16.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aptomed Medicines India?
In 2017, Aptomed Medicines India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Age-Management Medicine And Research India Private LimitedActive 16 years 10 monthsSamirkumar Shah is a mutual person
Anti Aging Medicine And Research IndiaActive 16 years 10 monthsDeepak Chaturvedi is a mutual person
- Vishwanjan Business Innovations Private LimitedActive 16 years 10 months
Deepak Chaturvedi and Samirkumar Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 31 Jan 2014 | ₹4.80 M | Open |
How Many Employees Work at Aptomed Medicines India?
Unlock and access historical data on people associated with Aptomed Medicines India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aptomed Medicines India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aptomed Medicines India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
